Addus HomeCare Corporation (ADUS) - Stock Analysis

Last updated: Sep 5, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.

Loading chart data...

Idea window: 10/20/2025 – 10/27/2025Sector: Healthcare

AI Analyst Overview

Last Price
$117.09
Market Cap
$2.19B
1D Return
-1.21%
YTD Return
+9.03%

Loading chart data...

Valuation Metrics

P/E
20.6
P/B
1.9
P/S
1.5
EV/EBITDA
13.4
Div Yield
—

Fundamental Analysis

7.0

Key Financial Insights: • Strong Cash Flow • Lower Debt • High Intangibles ADUS delivers solid profits, cash flow, and improving leverage, but its high intangible-asset exposure and moderate valuation warrant cautious monitoring.

CashGenerative
IntangibleRisk

Price Behavior

6.0

Key Price Behavior Insights: • Support rebound • Range-bound trading • Resistance test Support Level: $114.55–$114.70 Resistance Level: $120.80–$121.10 ADUS is cautiously constructive after rebounding from $114.55 support, but a sustained break above $120.80–$121.10 is needed to confirm upside momentum.

CautiouslyBullish
RangeBound

Sentiment & News

5.0

Key News Insights: • Golden cross • Stake reduction • COO transition ADUS faces mixed signals as a bullish golden cross is offset by a major institutional selloff and COO leadership transition.

ADUS
ManagementChange
AI

AI Summary

6.0
Neutral

ADUS is an execution-dependent compounder—not merely a defensive home-care play—where sustained margin and cash-flow gains could support modest upside, but the COO transition, labor/reimbursement pressure, and intangible-heavy balance sheet leave little valuation cushion near $119.

MarginExpansion
ExecutionRisk
HomeCareGrowth
AI summary updated 6 days ago

Description

Addus HomeCare provides in-home personal care, hospice, and home health services to elderly, chronically ill, disabled people and those at risk of hospitalization in the United States. Its Personal Care unit supplies non-medical assistance with daily living activities, the Hospice unit delivers palliative and family support services, and the Home Health unit offers skilled nursing and rehabilitative therapies. The company contracts with government programs, managed care organizations, commercial insurers and private clients, and as of December 31, 2021 operated 206 offices in 22 states; it was founded in 1979 and is based in Frisco, Texas.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Oct 20Oct 27ADUSAddus HomeCare Corporation
Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.
Closed+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.